Nutrition Research
Volume 29, Issue 2 , Pages 106-113 , February 2009

G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects

  • Oh Yoen Kim

      Affiliations

    • Clinical Nutrigenetics/Nutrigenomics Lab, Department of Food and Nutrition, College of Human Ecology, Yonsei University, 120-749 Seoul, Korea
    • Yonsei University Research Institute of Science for Aging, Yonsei University, 120-749 Seoul, Korea
    • These authors contributed equally to this work.
    • ,
  • Seog Hyun Jo

      Affiliations

    • Interdisciplinary program: Science for Aging, The Graduate School, Yonsei University, 120-749 Seoul, Korea
    • These authors contributed equally to this work.
    • ,
  • Yangsoo Jang

      Affiliations

    • Yonsei University Research Institute of Science for Aging, Yonsei University, 120-749 Seoul, Korea
    • Interdisciplinary program: Science for Aging, The Graduate School, Yonsei University, 120-749 Seoul, Korea
    • Division of Cardiology, Cardiovascular Genome Center, Yonsei Medical Institute, Yonsei University, 120-749 Seoul, Korea
    • ,
  • Jey Sook Chae

      Affiliations

    • Clinical Nutrigenetics/Nutrigenomics Lab, Department of Food and Nutrition, College of Human Ecology, Yonsei University, 120-749 Seoul, Korea
    • Yonsei University Research Institute of Science for Aging, Yonsei University, 120-749 Seoul, Korea
    • ,
  • Ji Young Kim

      Affiliations

    • Clinical Nutrigenetics/Nutrigenomics Lab, Department of Food and Nutrition, College of Human Ecology, Yonsei University, 120-749 Seoul, Korea
    • Yonsei University Research Institute of Science for Aging, Yonsei University, 120-749 Seoul, Korea
    • ,
  • Yae Jung Hyun

      Affiliations

    • Clinical Nutrigenetics/Nutrigenomics Lab, Department of Food and Nutrition, College of Human Ecology, Yonsei University, 120-749 Seoul, Korea
    • Department of Food and Nutrition, Brain Korea 21 Project, Yonsei University College of Human Ecology, 120-749 Seoul, Korea
    • ,
  • Jong Ho Lee

      Affiliations

    • Clinical Nutrigenetics/Nutrigenomics Lab, Department of Food and Nutrition, College of Human Ecology, Yonsei University, 120-749 Seoul, Korea
    • Yonsei University Research Institute of Science for Aging, Yonsei University, 120-749 Seoul, Korea
    • Department of Food and Nutrition, Brain Korea 21 Project, Yonsei University College of Human Ecology, 120-749 Seoul, Korea
    • Corresponding Author InformationCorresponding author. Department of Food and Nutrition, College of Human Ecology, Yonsei University, 134 Shinchon-dong, Sudaemun-gu, Seoul 120-749, Korea. Tel.: +82 2 2123 3122; fax: +82 2 364 9605.

Received 15 September 2008 ,Revised 20 December 2008 ,Accepted 26 January 2009.

References 

  1. Mello MM, Studdert DM, Brennan TA. Obesity—the new frontier of public health law. N Engl J Med. 2006;354:2601–2610
  2. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 2007;356:213–215
  3. Shuldiner AR. Obesity genes and gene-environment-behavior interactions: recommendations for a way forward. Obesity. 2008;16:S79–S81
  4. Chronic Disease Surveillance Team . The Korean National Health and Nutrition Survey. Seoul, Korea: Korea centers for disease control and prevention; 2007;
  5. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract. 2006;71:92–100
  6. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  7. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52:2097–2101
  8. Festa A, D'Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25:1407–1415
  9. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799–1804
  10. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110:1564–1571
  11. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation and RAGE:a scaffold for the macrovascular complications of diabetes and beyond. Cir Res. 2003;93:1159–1169
  12. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE is a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949–955
  13. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889–901
  14. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res. 2003;93:1159–1169
  15. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269:9889–9897
  16. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Bio Chem. 1997;272:17810–17814
  17. Zill H, Bek S, Hofmann T, Huber J, Frank O, Lindenmeier M, et al. RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem Biophys Res Commun. 2003;300:311–315
  18. Sousa MM, Yan SD, Stern D, Saraiva MJ. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor κB (NF-κB) activation. Lab Invest. 2000;80:1101–1110
  19. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 2002;61:148–156
  20. Galichet A, Weibel M, Heizmann CW. Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem Biophys Res Commun. 2008;370:1–5
  21. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, et al. A soluble form of the receptor for advanced glycation end products (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008;22:3716–3727
  22. Malherbe P, Richards JG, Gaillard H, Thompson A, Diener C, Schuler A, et al. cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res. 1999;71:159–170
  23. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 2003;370:1097–1099
  24. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol. 2005;25:1032–1037
  25. Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, et al. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes andperipheral blood mononuclear cells. Mol Immunol. 2004;40:1203–1211
  26. Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Inest. 2007;25:720–725
  27. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Per-Henrik Groop. The functional-374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes. 2003;52:891–894
  28. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes. 1998;47:1155–1157
  29. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002;3:123–135
  30. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and non obese Koreans. Metabolism. 2007;56:199–205
  31. Moon OR, Kim NS, Jang SM. The relationship between body mass index and the prevalence of obesity-related diseases based on the 1995 National Health Interview Survey in Korea. Obes Rev. 2002;3:191–196
  32. Moshides JS. Kinetic enzymatic method for automated determination of HDL cholesterol in plasma. J Clin Chem Clin Biochem. 1987;25:583–587
  33. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  34. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem. 1991;266:7329–7332
  35. Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem. 2004;279:50019–50024
  36. Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, et al. C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension. 2006;48:504–511
  37. Galler A, Müller G, Schinzel R, Kratzsch J, Kiess W, Münch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA. Diabetes Care. 2003;26:2609–2615
  38. Miura J, Yamagishi S, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, et al. Serum levels of non-carboxymethyllysine advanced glycation end products are correlated to severity of microvascular complications in patients with Type 1 diabetes. J Diabetes Complications. 2003;17:16–21
  39. Wagner Z, Wittmann I, Mazák I, Schinzel R, Heidland A, Kientsch-Engel R, et al. N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis. 2001;38:785–791
  40. Furth AJ. Glycated protein in diabetes. Br J Biomed Sci. 1997;54:192–200
  41. Tan KC, Chow WS, Tam S, Bucala R, Betteridge J. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care. 2004;27:223–228
  42. Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:2587–2593

PII: S0271-5317(09)00020-7

doi: 10.1016/j.nutres.2009.01.006

Nutrition Research
Volume 29, Issue 2 , Pages 106-113 , February 2009

Article Tools

* Image Usage & Resolution